Lu Yong, Inspiration for 'Dying to Survive', Begins Cutting CML Medication After 20 Years
The Facts
- Lu Yong, a 58-year-old chronic myeloid leukaemia (CML) patient, has begun reducing his medication and hopes to stop it completely within three months. SCMP only
- Lu's experience inspired the 2018 film 'Dying to Survive'. SCMP only
- Lu helped patients across China obtain affordable generic drugs from India and was prosecuted by Chinese authorities for selling 'fake drugs'. SCMP only
- Lu was a textiles trader in Jiangsu province before his diagnosis with CML in 2002. SCMP only
- After diagnosis, Lu took Gleevec, a patented Novartis drug, for the first few years. SCMP only
Dive deeper · 1 more factShow less
- SCMP reports Chinese health authorities fast-tracked healthcare reforms for cancer patients after the film's release. SCMP only
Context
Lu Yong, whose story was the basis for the 2018 Chinese film 'Dying to Survive', has started reducing his CML medication, according to SCMP. He hopes to stop treatment within three months.
Lu was diagnosed in 2002 and initially took Novartis's Gleevec. He later helped patients obtain cheaper generic drugs from India and was prosecuted for selling 'fake drugs'. The headline figure of 35,000 pills over two decades comes from SCMP's title.
How the Agent Panel Scored This
Independent AI personas each scored importance 1–10; the story's score is a trimmed mean (highest and lowest votes dropped). Vote spread: 0.
| 2 | News Editor | This is a personal medical development for one patient reported by a single source, a niche human-interest story with limited broad impact and no major concrete public action. |
| 2 | Business Analyst | This is a personal health update about one patient reducing medication, a niche human-interest story with no market-moving data, corporate action, or regulatory shift. |
| 2 | Informed Citizen | This is a personal medical update about one patient reducing his medication, with limited impact on ordinary people beyond human-interest interest. |